Clinical Trial Update: A Placebo-Controlled Study of MK0634 in Patients With Overactive Bladder (0634-007) [Phase 2]

View source ↗

Summary

Phase 2 placebo-controlled trial of MK0634 for overactive bladder/urinary incontinence has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urinary Incontinence

Drugs mentioned

• MK0634

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Urinary Incontinence | Phase 2 | Status: COMPLETED